FLYLF yields 825.08% · PFE yields 6.13%● Live data
📍 FLYLF pulled ahead of the other in Year 1
Combined, FLYLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FLYLF + PFE for your $10,000?
FLYHT Aerospace Solutions Ltd. provides real-time communications with aircrafts for the aerospace industry. It offers AFIRS, an automated flight information reporting system that is a satcom aircraft interface device, which enables real-time streaming of flight information, cockpit voice, and black box data streaming; TAMDAR, a tropospheric airborne meteorological data reporting system that aggregates and streams airborne weather data in real-time; AirMap, which provides real-time monitoring and insight of fleets; and UpTime, a ground-based, enterprise server that communicates with AFIRS through satellite connectivity and serves its customers with real-time applications. The company also offers FLYHTStream, a technology that performs real-time triggered alerting and black-box data streaming in the event of an abnormal situation in aircraft; FLYHTLog, which enables operators to monitor the status of their aircraft and have detailed out, off, on, and in time information; FLYHTVoice, a private communication channel for flight deck; and FLYHTMail, a two-way text messaging system for the flight crew and dispatch personnel. In addition, it provides aircraft health monitoring and automated engine trend reporting systems; and FLYHT Weather Observations that offers real-time weather data. It serves in the United States, Mexico, Asia, China, the Middle East, Canada, Australia, Africa, Europe, and South/Central America. The company was formerly known as AeroMechanical Services Ltd. and changed its name to FLYHT Aerospace Solutions Ltd. in May 2012. FLYHT Aerospace Solutions Ltd. was founded in 1998 and is headquartered in Calgary, Canada.
Full FLYLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.